![New Study Shows HPV Vaccination Significantly Reduces Prevalence of High-Risk HPV Infections in Rwanda](https://oncodaily.com/pub/uploads/2023/06/IARC-943x1280.jpeg)
Photo: IARC/Linkedin
Jun 2, 2023, 05:54
New Study Shows HPV Vaccination Significantly Reduces Prevalence of High-Risk HPV Infections in Rwanda
IARC, the Ministry of Health of Rwanda, and their partners. “New study from IARC, the Ministry of Health of Rwanda, & partners shows vaccination against human papillomavirus HPV more than halved prevalence of infection with high-risk HPV types in country in less than 8 yrs.” The Lancet Global Health.
Source: IARC/Linkedin
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023